ACTH ELISA

About Biomerica

Biomerica is a publicly traded diagnostic company with a mission to improve quality of life through high-performing diagnostic products. It leverages a portfolio of over 100 filed patents and a broad product line across multiple disease areas, including gastrointestinal disorders, diabetes, and endocrinology. The company's strategic vision is to become a leader in diagnostic-guided therapies, particularly for IBS, and it maintains a strong scientific advisory board comprised of leading gastroenterologists. Its business model combines proprietary product development with contract manufacturing services for other pharmaceutical and diagnostic organizations.

Therapeutic Areas